Supernus Pharmaceuticals ... (SUPN)
NASDAQ: SUPN
· Real-Time Price · USD
43.27
1.10 (2.61%)
At close: Aug 15, 2025, 12:01 PM
13F Institute Ownership
Total Institutes of 290 in Supernus Pharmaceuticals reduced their positions with a decrease of 5 investors compared to the previous quarter. A reduction of 418.48K shares, as total invested capital declined by $215.39M with ownership percentage dropping from 107.89% to 105.76%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.716
0.72
Call Flow 8,800
58%
Put Flow 6,300
42%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Blackrock, Inc. | 17.34% | 9.68M | -3.13% | 317.17M | < 0.01% | May 02, 2025 |
| Vanguard Group Inc | 11.03% | 6.16M | +0.21% | 201.87M | < 0.01% | May 09, 2025 |
| Armistice Capital, LLC | 9.30% | 5.2M | +7.44% | 170.17M | 2.55% | May 15, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.